To elucidate whether or not the inhibition of NLRP3 inflammasome activation by GKB depends on autophagy modulation, we treated the lung cancer cells with an autophagy inhibitor (3-MA) and knocked down beclin-1. This evidence concerns the gene NLRP3 and lung cancer.